Pan-Asia Index Rebalances/ Events/ Delta One, Periscope Analytics

Brian Freitas

Pan-Asia Index Rebalances/ Events/ Delta One

Periscope Analytics

Periscope Analytics focuses on event-driven trades across Asia Pacific and provides comprehensive, timely and systematic coverage of index changes to major Asia Pacific indices in a structured manner.

The analysis includes forecasted inclusions and exclusions to all major Asian indices that have significant amount of tracking assets, including estimates of passive buy/sell flow on the stocks. The service also provides commentary and impact of market consultations, ground rule changes, and other events (IPOs, spin-offs, M&A) that could lead to index changes and passive flow.

Periscope Analytics works with multi-strategy hedge funds, proprietary trading firms, stat arb trading groups and long-only investors that invest and trade in the Asia Pacific region with the data being used to trade index rebalances, avoid pre-positioning and passive flow, and to time entry into and exit from stocks.

Event-Driven Trades Across Asia Pacific

Index Rebalance

<ul>
<li>
<a href="https://www.smartkarma.com/entities/trent-ltd" target="_blank" data-smartkarma-citation="entities:8410:1" rel="noopener">Trent (TRENT IN)</a> and <a href="https://www.smartkarma.com/entities/bharat-electronics-ltd" target="_blank" data-smartkarma-citation="entities:6636:1" rel="noopener">Bharat Electronics (BHE IN)</a> will replace <a href="https://www.smartkarma.com/entities/ltimindtree-ltd" target="_blank" data-smartkarma-citation="entities:22778:1" rel="noopener">LTIMindtree (LTIM IN)</a> and <a href="https://www.smartkarma.com/entities/divi-s-laboratories-ltd" target="_blank" data-smartkarma-citation="entities:4871:1" rel="noopener">Divi's Laboratories (DIVI IN)</a> in the <a href="https://www.smartkarma.com/entities/nifty-index" target="_blank" data-smartkarma-citation="entities:23617:1" rel="noopener">NIFTY Index (NIFTY INDEX)</a> at the close on 27 September.</li>
<li>Passive trackers will need to trade at least 5 days of ADV and over 11 days of delivery volume in the stocks.</li>
<li>All the index changes are also changes for the <a href="https://www.smartkarma.com/entities/nse-nifty-next-50-index" target="_blank" data-smartkarma-citation="entities:36053:1" rel="noopener">NSE Nifty Next 50 Index (NIFTYJR INDEX)</a> and there will be opposing flows (though much smaller in size) for the stocks.</li>
</ul>



Trent (TRENT IN) and Bharat Electronics (BHE IN) will replace LTIMindtree (LTIM IN) and Divi's Laboratories (DIVI IN) in the NIFTY Index (NIFTY INDEX) at the close on 27 September.
Passive trackers will need to trade at least 5 days of ADV and over 11 days of delivery volume in the stocks.
All the index changes are also changes for the NSE Nifty Next 50 Index (NIFTYJR INDEX) and there will be opposing flows (though much smaller in size) for the stocks.


NIFTY50 Index Rebalance: Trent, BEL to Replace Divi's Lab, LTIMindtree

Global Healthcare Analyst

Tina Banerjee

Thematic (Sector/Industry)

<ul>
<li>Q1FY25 results of the leading Indian pharmaceutical companies showed healthy and broad-based growth of the Indian pharmaceutical market, which grew 8.7% in Q1FY25.</li>
<li>Most of the top listed players registered double-digit revenue growth from their respective India formulation segments. Focus on chronic therapies remained major growth driver.</li>
<li>The Nifty Pharma Index has outperformed the benchmark Nifty 50, rising 32% YTD. The benchmark index has gained just 13% over the same period.</li>
</ul>


Q1FY25 results of the leading Indian pharmaceutical companies showed healthy and broad-based growth of the Indian pharmaceutical market, which grew 8.7% in Q1FY25.
Most of the top listed players registered double-digit revenue growth from their respective India formulation segments. Focus on chronic therapies remained major growth driver.
The Nifty Pharma Index has outperformed the benchmark Nifty 50, rising 32% YTD. The benchmark index has gained just 13% over the same period.


Indian Pharmaceutical Market: On A Healthy Growth Path; Momentum to Continue in Rest of the Year

Head of Trading/ Partner, AceGama Advisors

Sankalp Singh

Head of Trading/ Partner

Proprietary Trading Desk

AceGama Advisors

Trading desk specializing in the Listed & OTC options strategies for risk management & investment purposes.

Equity Derivatives

<ul>
<li>Risk premia higher early in the week as Local Markets are disappointed with MSCI decision regarding HDFC Bank. IVs get marked up across the board.</li>
<li>Positive Global Macro data bolsters Equity Markets later in the week. IVs trade lower. Smile &amp; Skew characteristics compress as well and Vol Term-structure flattened out.    </li>
<li>Vol Regime Model retains "High &amp; Down" state. Short Iron Condor/ Short Iron Butterfly type structures recommended to align with the current volatility environment.</li>
</ul>


Risk premia higher early in the week as Local Markets are disappointed with MSCI decision regarding HDFC Bank. IVs get marked up across the board.
Positive Global Macro data bolsters Equity Markets later in the week. IVs trade lower. Smile &amp; Skew characteristics compress as well and Vol Term-structure flattened out.    
Vol Regime Model retains "High &amp; Down" state. Short Iron Condor/ Short Iron Butterfly type structures recommended to align with the current volatility environment.


EQD / NSE Vol Update / IVs Oscillate  - Reacting First To MSCI-HDFC News & Later to U.S. Inflation

<ul>
<li>IVs move higher in a controlled manner relative to U.S. markets. Combination of technical factors put a dampener on the Options Markets &amp; IV turn lower by Week's end.</li>
<li>Many determining factors underwent changes in Vol-Regime Model  - but threshold to switch out of "High &amp; Down" state not achieved.</li>
<li>Smile &amp; Skew characteristics blow out significantly on the open but settle at lower levels by week's close.</li>
</ul>


IVs move higher in a controlled manner relative to U.S. markets. Combination of technical factors put a dampener on the Options Markets &amp; IV turn lower by Week's end.
Many determining factors underwent changes in Vol-Regime Model  - but threshold to switch out of "High &amp; Down" state not achieved.
Smile &amp; Skew characteristics blow out significantly on the open but settle at lower levels by week's close.


EQD / NSE Vol Update / Controlled Detonation in Vols - Initial Jump Followed by Calmer Levels

Market & Forensics Analyst, Beat the Street

Nimish Maheshwari

Market & Forensics Analyst

Beat the Street

Beat The Street was founded by Nimish Maheshwari and Sudarshan Bhandari, both of whom are Chartered Accountants by Profession, known for their expert analysis in the fields of Business, Sectoral analysis, and Corporate governance.

With a strong social media presence of 45,000+ Subscribers across various platforms, they are considered trusted voices in the industry. Their insights and analysis have been featured in some of India’s most prominent publications, including the Economic Times, Dalal Street Investment Journal, The Morning Context, and The Ken.

Their analysis on Bankrupt & Insolvent companies has been instrumental in saving investors from significant losses. They have a keen eye for identifying red flags and has identified exclusive redflags earlier in Vedanta, Nykaa, Dhani Services, Adani and many more.

Read Business Not Stock Prices

<ul>
<li>Markets have a tendency to bounce back after steep falls, offering opportunities for investors to benefit from the recovery. </li>
<li>By understanding historical data and market patterns, investors can make informed decisions and stay resilient during turbulent times.</li>
<li>As we move forward, it's important to remember that market fluctuations are a normal part of investing, and staying focused on long-term goals is crucial for success.</li>
</ul>


Markets have a tendency to bounce back after steep falls, offering opportunities for investors to benefit from the recovery. 
By understanding historical data and market patterns, investors can make informed decisions and stay resilient during turbulent times.
As we move forward, it's important to remember that market fluctuations are a normal part of investing, and staying focused on long-term goals is crucial for success.


Thematic Report : How Indian Markets Performed After Steep Falls

India

The NIFTY 50 index is National Stock Exchange of India's benchmark stock market index for Indian equity market. Nifty is owned and managed by India Index Services and Products (IISL), which is a wholly owned subsidiary of the NSE Strategic Investment Corporation Limited.

NIFTY Index (NIFTY INDEX)

NIFTY50 Index Rebalance: Trent, BEL to Replace Divi's Lab, LTIMindtree

Trent and Bharat Electronics will replace LTIM and Divi Lab in the NIFTY50. There is over 5x ADV/11x delivery volume to trade in the stocks. There...

Brian Freitas

Indian Pharmaceutical Market: On A Healthy Growth Path; Momentum to Continue in Rest of the Year

Indian pharmaceutical market grew 8.7% in Q1FY25. Most of the top players reported double-digit revenue growth in domestic market. Nifty Pharma...

Tina Banerjee

EQD / NSE Vol Update / IVs Oscillate - Reacting First To MSCI-HDFC News & Later to U.S. Inflation

IVs react to negative news w.r.t. MSCI-HDFC decision & later to positive Global Macro data. Eventually IVs close lower on Weekly basis. Volatility...

AceGama Advisors

EQD / NSE Vol Update / Controlled Detonation in Vols - Initial Jump Followed by Calmer Levels

MSCI's decides to split HDFC Bank's re-weighting between August & November 2024. HDFC Bank down -3.5% as a result, dragging BankNifty & Nifty50...

AceGama Advisors

Thematic Report : How Indian Markets Performed After Steep Falls

Thematic Report: How Indian Markets Performed After Steep Fall? Historical data suggest crisis-like events suggest an opportunity to buy the fear...

Nimish Maheshwari

NIFTY50 Index Rebalance: Trent, BEL to Replace Divi's Lab, LTIMindtree

Trent and Bharat Electronics will replace LTIM and Divi Lab in the NIFTY50. There is over 5x ADV/11x delivery volume to trade in the stocks. There...

Brian Freitas

Indian Pharmaceutical Market: On A Healthy Growth Path; Momentum to Continue in Rest of the Year

​Indian pharmaceutical market grew 8.7% in Q1FY25. Most of the top players reported double-digit revenue growth in domestic market. Nifty Pharma...

Tina Banerjee

EQD / NSE Vol Update / IVs Oscillate - Reacting First To MSCI-HDFC News & Later to U.S. Inflation

​IVs react to negative news w.r.t. MSCI-HDFC decision & later to positive Global Macro data. Eventually IVs close lower on Weekly basis. Volatility...

AceGama Advisors

EQD / NSE Vol Update / Controlled Detonation in Vols - Initial Jump Followed by Calmer Levels

MSCI's decides to split HDFC Bank's re-weighting between August & November 2024. HDFC Bank down -3.5% as a result, dragging BankNifty & Nifty50...

AceGama Advisors

Thematic Report : How Indian Markets Performed After Steep Falls

Thematic Report: How Indian Markets Performed After Steep Fall? Historical data suggest crisis-like events suggest an opportunity to buy the fear...

Nimish Maheshwari

Indian pharmaceutical market grew 8.7% in Q1FY25. Most of the top players reported double-digit revenue growth in domestic market. Nifty Pharma...

IVs react to negative news w.r.t. MSCI-HDFC decision & later to positive Global Macro data. Eventually IVs close lower on Weekly basis. Volatility...